A Scallop Derived Brain Supplement Improved Memory, in a Trial the Company Selling It Paid For
Plasmalogens are about to become a name you see on cognitive supplement labels, and I would rather you understand the actual trial behind that name before the marketing arrives than after. A randomized, double blind, placebo controlled trial in 66 Japanese adults over 40 with below average verbal memory found that 1 milligram a day of purified scallop derived plasmalogens, taken for 12 weeks, produced significantly higher verbal memory and attention scores than placebo. The trial was funded by B&S Corporation, the company that manufactures and sells the ingredient.
- In a randomized, double blind, placebo controlled trial, 66 Japanese adults over 40 with below average memory took 1 milligram a day of scallop derived plasmalogens for 12 weeks and scored significantly higher on verbal memory and attention than the placebo group.
- The trial was funded by B&S Corporation, the company that manufactures and markets scallop derived plasmalogen.
- Plasma BDNF, the brain health marker that would have explained how the ingredient works, showed no significant difference between groups, and the researchers describe the effect size's confidence interval as wide with a p value close to the threshold for significance.
- Plasmalogens occur naturally in scallops, mussels, salmon, pork, chicken, eggs and brown algae, so you can take in the same class of compound without buying a supplement.
- 66
- Adults over 40 in the trial, all with below average verbal memory
- 12
- Weeks of daily dosing
- 1mg
- Daily dose of purified scallop derived plasmalogens
- 0
- Significant difference in plasma BDNF, the brain marker that would have explained the mechanism
What plasmalogens actually are, and why researchers care
Plasmalogens are a specialized class of phospholipid, the fats that build cell membranes, and they make up roughly a fifth of all human phospholipids. They are especially concentrated in nervous, immune and cardiovascular tissue, and plasmalogen deficiency has been linked to Alzheimer's and Parkinson's disease. In animal research, giving plasmalogens has suppressed inflammation related microglial activation and reduced amyloid buildup and neuron loss. The hard part has always been delivery. Plasmalogens are chemically unstable, poorly absorbed when taken by mouth, and have to cross the blood brain barrier to do anything in the brain, which is why a trial that shows any oral effect at all is worth a close look.
What the trial found, and what it didn't
The 66 participants, all over 40 with verbal memory below the age matched normal range and no diagnosed disease, were randomized to the plasmalogen supplement or a placebo for 12 weeks. Researchers assessed memory and 16 other cognitive domains at the start and end, along with plasma BDNF, brain derived neurotrophic factor, as a marker of brain health. Verbal memory scores were significantly higher in the supplement group, described by the researchers as a moderate effect, and attention scores were higher too. A subgroup analysis found the memory benefit only in participants without a four year college degree, not in those with one. Plasma BDNF, the marker that would have explained the mechanism, showed no significant difference between groups. On safety, higher cholesterol was seen somewhat more often in the supplement group, which the researchers judged not clinically meaningful.
Plasma BDNF, the marker that would have explained the mechanism, showed no significant difference between groups.
Honest caveat
This is one small trial with real soft spots, and the researchers say so themselves. They describe the effect size as having a relatively wide confidence interval and a p value close to the conventional threshold for significance, and they explicitly say the results should be interpreted with caution and confirmed in larger studies. The study was funded by the company that manufactures and sells the ingredient, which does not make the finding false, but does mean it has not been independently confirmed. Sixty six people is a small sample, all of them Japanese and pre selected for below average memory, so how well this generalizes to a broader audience is unknown. The subgroup finding, that the benefit only showed up in participants without a bachelor's degree, is a post hoc split on an already small sample and should be treated as a hypothesis to test, not a result. And the one biological marker that would have supported the proposed mechanism, plasma BDNF, did not move at all. No retraction or contradicting trial turned up in the check, but earlier human research on scallop plasmalogens has also come from industry linked sources, so the entire evidence base for this ingredient right now is commercially funded.
What this means for you
If you see plasmalogens marketed as clinically proven for memory, this is the trial those claims will point to, and now you know exactly what it does and doesn't show. It is a real, peer reviewed, randomized human trial with a genuine biological rationale behind it, which is more than most new supplement ingredients can say. It is also small, single, industry funded, and missing the mechanism marker that would have made the case airtight. You do not need to buy anything to get plasmalogens into your diet. They occur naturally in scallops, mussels, salmon, pork, chicken, eggs and brown algae, so a food first approach is available to anyone curious about this ingredient before an independently funded replication exists.
A plate of seared sea scallops. This is the food, not the supplement: the trial's ingredient is a purified extract, but scallops themselves are one of the food sources of plasmalogens the researchers name.
Ralph DailyCC BY 2.0
Illustrative. Not the scallop species the trial studied (Mizuhopecten yessoensis, the Japanese Ezo giant scallop, typically eaten raw or in Japanese preparations) and not the purified plasmalogen extract itself, which is a supplement, not a plate of food. Shown because the article's own honest takeaway is that plasmalogens can be eaten, not only bought, and a real plate of scallops is the truest image of that.
Primary sources
- Fukuchi M, et al. Orally administered scallop derived plasmalogens improve cognitive function in healthy middle aged and older adults: a randomized, double blind, placebo controlled trial. Frontiers in Nutrition, 2026. Read the paper
- Scallop derived plasmalogens show promise for cognitive function. NutraIngredients, August 18, 2026. nutraingredients.com
Common questions
What are plasmalogens?
Plasmalogens are a specialized type of phospholipid, a fat that makes up cell membranes, and they account for roughly a fifth of all human phospholipids. They are especially concentrated in brain, immune and cardiovascular tissue, and plasmalogen levels are known to fall with age and to be lower in people with Alzheimer's and Parkinson's disease.
Should I trust this trial's memory result?
Treat it as an early, real signal rather than proof. It was a genuine randomized, placebo controlled trial, which counts for something, but it was small at 66 people, conducted in one country, funded by the company that manufactures and sells the ingredient, and the researchers' own writeup says the effect size sat right at the edge of statistical significance. The brain health marker that would have explained how it worked, BDNF, did not move at all.
Can I get plasmalogens without buying a supplement?
Yes. The researchers themselves note that plasmalogens occur naturally in scallops, mussels, salmon, pork, chicken, eggs and brown algae. Eating those foods is a way to take in the same class of compound the trial tested, without paying supplement prices for an ingredient whose evidence base is still this early.
Stay Curious.
Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.